{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:12Z","timestamp":1761514152891,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,26]]},"DOI":"10.7759\/cureus.95461","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:27:10Z","timestamp":1761514030000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Neuromyelitis Optica Spectrum Disorder: A Case of Unilateral Optic Neuritis and Partial Transverse Myelitis"],"prefix":"10.7759","author":[{"given":"Alaweya  A","family":"Ofash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhannad","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omnia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama S","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris","family":"Abdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius S","year":"2013","unstructured":"Jarius S, Wildemann B. The history of neuromyelitis optica. J Inflamm. 2013, 10:1-12. 10.1186\/1742-2094-10-8","journal-title":"J Inflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk DM","year":"2006","unstructured":"Wingerchuk DM, Lennon V, Pittock S, Lucchinetti C, Weinshenker B. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66:1485-9. 10.1212\/01.wnl.0000216139.44259.74","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk DM","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-15. 10.1016\/S1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)-revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius S","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I, et al.. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)-revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis. Journal of neurology. 2023, 270:3341-68. 10.1007\/s00415-023-11634-0","journal-title":"Journal of neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-189. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp V","year":"2021","unstructured":"Papp V, Magyari M, Aktas O, et al.. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021, 96:59-77. 10.1212\/WNL.0000000000011153","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius S","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020, 6:85. 10.1038\/s41572-020-0214-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103499","article-title":"Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: a comprehensive review","volume":"23","author":"Siriratnam P","year":"2024","unstructured":"Siriratnam P, Huda S, Butzkueven H, van der Walt A, Jokubaitis V, Monif M. Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: a comprehensive review. Autoimmun Rev. 2024, 23:103499. 10.1016\/j.autrev.2023.103499","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39687","article-title":"Neuromyelitis optica spectrum disorder with ultra-longitudinally extensive transverse myelitis: a case report and literature review","volume":"10","author":"Li F","year":"2024","unstructured":"Li F, Sui X, Pan X, et al.. Neuromyelitis optica spectrum disorder with ultra-longitudinally extensive transverse myelitis: a case report and literature review. Heliyon. 2024, 10:10.1016\/j.heliyon.2024.e39687","journal-title":"Heliyon"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10647-x","article-title":"Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2","volume":"269","author":"Helmchen C","year":"2022","unstructured":"Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. J Neurol. 2022, 269:49-54. 10.1007\/s00415-021-10647-x","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-018-0608-3","article-title":"Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions","volume":"9","author":"Mohajeri Moghaddam S","year":"2018","unstructured":"Mohajeri Moghaddam S, Bhatt AA. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imaging. 2018, 9:511-26. 10.1007\/s13244-018-0608-3","journal-title":"Insights Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168638","article-title":"Treatment of neuromyelitis optica spectrum disorders","volume":"22","author":"Chan KH","year":"2021","unstructured":"Chan KH, Lee CY. Treatment of neuromyelitis optica spectrum disorders. Int J Mol Sci. 2021, 22:10.3390\/ijms22168638","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management","volume":"271","author":"K\u00fcmpfel T","year":"2024","unstructured":"K\u00fcmpfel T, Giglhuber K, Aktas O, et al.. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management. J Neurol. 2024, 271:141-76. 10.1007\/s00415-023-11910-z","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf257","article-title":"Brain corticospinal tract abnormalities in aquaporin-4 seropositive neuromyelitis optica spectrum disorder with longitudinally extensive transverse myelitis","volume":"257","author":"Zhang C","year":"2025","unstructured":"Zhang C, Yao Y, Sun J, et al.. Brain corticospinal tract abnormalities in aquaporin-4 seropositive neuromyelitis optica spectrum disorder with longitudinally extensive transverse myelitis. Brain Commun. 2025, 257:10.1093\/braincomms\/fcaf257","journal-title":"Brain Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515581438","article-title":"Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange","volume":"22","author":"Abboud H","year":"2016","unstructured":"Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler J. 2016, 22:185-92. 10.1177\/1352458515581438","journal-title":"Mult Scler J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10429","article-title":"Longitudinally extensive transverse myelitis in a lupus-neuromyelitis optica overlap","volume":"12","author":"Tavor Y","year":"2021","unstructured":"Tavor Y, Herskovitz M, Ronen G, Balbir-Gurman A. Longitudinally extensive transverse myelitis in a lupus-neuromyelitis optica overlap. Rambam Maimonides Med J. 2021, 12:6. 10.5041\/RMMJ.10429","journal-title":"Rambam Maimonides Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix C","year":"2007","unstructured":"Papeix C, Vidal JS, de Seze J, et al.. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007, 13:256-259. 10.1177\/1352458506070732","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-007-0730-5","article-title":"Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis","volume":"255","author":"Shimizu Y","year":"2007","unstructured":"Shimizu Y, Yokoyama K, Misu T, et al.. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol. 2007, 255:305-7. 10.1007\/s00415-007-0730-5","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-015-0378-x","article-title":"Acute and chronic management of neuromyelitis optica spectrum disorder","volume":"17","author":"Sherman E","year":"2015","unstructured":"Sherman E, Han MH. Acute and chronic management of neuromyelitis optica spectrum disorder. Curr Treat Options Neurol. 2015, 17:1-14. 10.1007\/s11940-015-0378-x","journal-title":"Curr Treat Options Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394453-atypical-neuromyelitis-optica-spectrum-disorder-a-case-of-unilateral-optic-neuritis-and-partial-transverse-myelitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:27:11Z","timestamp":1761514031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394453-atypical-neuromyelitis-optica-spectrum-disorder-a-case-of-unilateral-optic-neuritis-and-partial-transverse-myelitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95461","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,26]]}}}